Crinetics Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 83.63 USD | 84 USD | 25,83 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 85,5 USD | 11 | 5 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 105.840.233 | 6,87 | 0,84 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Crinetics Pharmaceuticals Inc
Mitarbeiter 594
Handelsplatz NASDAQ
Ticker Symbol CRNX
IPO Datum 2018-07-18
Adresse 6055 Lusk Boulevard, San Diego, CA, United States, 92121
Webseite https://www.crinetics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. R. Scott Struthers Ph.D. | Founder, President, CEO & Director |
| 2 | Dr. Stephen F. Betz Ph.D. | Co-Founder & Chief Scientific Officer |
| 3 | Mr. Tobin C. Schilke | Chief Financial Officer |
| 4 | Mr. Kea Lingo | Chief Information Officer |
| 5 | Ms. Gayathri Diwakar | Head of Investor Relations |
| 6 | Ms. Garlan Adams J.D. | Chief Legal Officer & Corporate Secretary |
| 7 | Natalie Badillo | Head of Corporate Communications |
| 8 | Ms. Adriana C. Cabre M.B.A. | Chief Human Resources Officer |
| 9 | Dr. Alan S. Krasner M.D. | Chief Endocrinologist |
| 10 | Mr. Kevin Capps | Head of Intellectual Property |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | Farallon Capital Management, L.L.C. | 0,00% | 0,00 Mio. USD |
| 5 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 6 | Driehaus Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 7 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 11 | EcoR1 Capital, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Bellevue Group AG | 0,00% | 0,00 Mio. USD |
| 13 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 15 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 16 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 17 | Siren, L.L.C. | 0,00% | 0,00 Mio. USD |
| 18 | Pictet Asset Manangement SA | 0,00% | 0,00 Mio. USD |
| 19 | BNP Paribas Investment Partners SA | 0,00% | 0,00 Mio. USD |
| 20 | GW&K Investment Management, LLC | 0,00% | 0,00 Mio. USD |